Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain. Dr.

Case Study Epitomizing Results from RESTORE EF  

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

RESTORE EF Case Study: Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Building Collaboration Between Interventionalists and Cardiac Surgeons

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella™.

STEMI-DTU RCT and the Radical, Disruptive Concept of Delayed Reperfusion

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

ECpella versus ECMO in Cardiogenic Shock: Two Independent Meta-analyses

Mario Iannaccone, MD and Vasileios Panoulas, MD, discuss two meta-analyses demonstrating improved survival in cardiogenic shock managed with ECMO and Impella (ECpella™) versus ECMO alone.

Rollout of the PROTECT IV Trial at Dresden Heart Center

Charles Simonton, MD, interviews Prof. Norman Mangner, MD, from Dresden Heart Center, about the rollout of the PROTECT IV trial. The interview focuses on an update on the PROTECT IV trial in light of the upcoming Investigator Meeting at the EuroPCR in Paris in May 2022.

STEMI DTU Rollout at the Heart and Vascular Center Essen

The focus of the interview between Charles Simonton, MD, and PD Fadi Al-Rashid, MD, is an update on the STEMI DTU trial in light of the investigator meeting at EuroPCR in Paris in May 2022.

Interview Dr. Mario Iannaccone: Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis

Dr. Mario Iannaccone is interviewed on "Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis".

Interview Dr. Chieffo - Joint EAPCI /ACVC Expert Consensus Document on Percutaneous Ventricular Assist

Dr. Alaide Chieffo on the views of an expert panel and appraises the value of short-term pVAD.

ISICEM 2021: ABIOMED Symposia Prof. Susanna Price, Prof. Roberto Lorusso  

Updates on transient mechanical circulatory support in cardiogenic shock

EuroPCR 2021 Digital – Abiomed Symposia Recordings

EuroPCR 2021: Sharing knowledge, skills, and experience. In the digital symposium by ABIOMED you will learn all about the importance of extensive…

Interview with Dr. Pappalardo on “Optimal ICU Management of Patients Requiring Hemodynamic Support with an Impella® Device"

ICU management of Impella patients can be challenging. The growing need for guidance in patient selection, therapy strategies, escalation and weaning led a group of experts to the publication of a European Heart Journal supplement with 8 individual manus.

European Heart Journal Supplements: Impella® Beyond the Cathlab: Open Issues and Clinical Needs

STATUS QUO 2020: what have we learned so far in temporary mechanical circulatory support? Use of Impella beyond the cathlab: open issues and clinical…

IMP-IT Subgroup Analysis on Timing of Impella® and Outcomes in Cardiogenicshock or High-Risk Percutaneous Coronary Revascularization Now Published In: Catheter Cardiovasc Interv. 2021;1–13.

This is the largest European series of patients with Impella support demonstrating real-life data about Impella usage during the last years.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].